Eom Bang Wool, Jung Kyu-Won, Won Young-Joo, Kim Young-Woo
Center for Gastric Cancer, National Cancer Center, Goyang, Korea.
Cancer Registration and Statistics Branch, National Cancer Control Institute, Goyang, Korea.
J Gastric Cancer. 2019 Mar;19(1):92-101. doi: 10.5230/jgc.2019.19.e5. Epub 2019 Feb 20.
The aim of this study was to evaluate the trend of non-compliance with treatment (NCT) among gastric cancer patients in the Korean population.
Using data from the Korea Central Cancer Registry from 1999 to 2015, patients who did not receive any treatment for gastric cancer within 4 months after diagnosis were defined as the NCT group. The annual incidence rate, distributions according to age group and stage, and 5-year relative survival of the patients exhibiting NCT were analyzed.
The number of NCT patients was 5,871 (30.6%) in 1999 and continuously decreased to 4,434 (15.3%) in 2015. Between 2006 and 2015, the proportions of NCT patients decreased from 72.9% to 55.0% among those 80 years old or older and from 9.2% to 5.4% among patients younger than 40 years. In patients with distant metastases, this proportion decreased from 35.5% to 32.7%, and this proportion also decreased from 17.6% to 8.2% among those with localized disease. The 5-year relative survival rates of NCT patients between 2011 and 2015 were significantly lower than those of the treated patients in each stage (60.2% vs. 99.7%, 13.8% vs. 67.1%, and 2.0% vs. 8.3% among those with localized, regional, and distant disease, respectively).
The proportion of NCT gastric cancer patients has decreased during the last 16 years. However, considerable numbers of elderly patients are still NCT. There must be a strategy to decrease NCT and improve the nationwide survival rate of patients with gastric cancer.
本研究旨在评估韩国人群中胃癌患者的治疗不依从(NCT)趋势。
利用韩国中央癌症登记处1999年至2015年的数据,将诊断后4个月内未接受任何胃癌治疗的患者定义为NCT组。分析了出现NCT的患者的年发病率、按年龄组和分期的分布以及5年相对生存率。
1999年NCT患者数量为5871例(30.6%),并持续下降至2015年的4434例(15.3%)。2006年至2015年期间,80岁及以上患者中NCT患者的比例从72.9%降至55.0%,40岁以下患者中这一比例从9.2%降至5.4%。在有远处转移的患者中,这一比例从35.5%降至32.7%,在局限性疾病患者中这一比例也从17.6%降至8.2%。2011年至2015年期间,各阶段NCT患者的5年相对生存率均显著低于接受治疗的患者(局限性、区域性和远处疾病患者中分别为60.2%对99.7%、13.8%对67.1%、2.0%对8.3%)。
过去16年中,NCT胃癌患者的比例有所下降。然而,仍有相当数量的老年患者存在NCT情况。必须制定一项策略以降低NCT并提高全国胃癌患者的生存率。